Evidence mapPaperPMID 41742016Full record

ArticleBMC microbiology2026

Gut microbiota characteristics and its biological function analysis in patients with tuberculosis and diabetes mellitus co-morbidity.

Feifan Xu, Jingjing Ren, Juan Ma, Lingqin Zhang, Shengyan Qu, Wei Zhang

Abstract read
In one paragraph

Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Feifan Xu *Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, P.R. China.
Jingjing Ren *Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, P.R. China.
Juan Ma *Department of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, P.R. China.
Lingqin ZhangDepartment of Tuberculosis, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, P.R. China.
Shengyan QuDepartment of Clinical Laboratory, Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), Nantong, P.R. China.
Wei ZhangDepartment of Infectious Diseases, Taizhou People's Hospital Affiliated to Nanjing Medical University, Taizhou, P.R. China. tzweizhang@126.com.

Funding

Jiangsu Municipal Health Commission Z2023069Jiangsu Provincial Health Commission Scientific Researh Project YI2023023Nantong Municipal Health Commission QN2023042Nantong Municipal Health Commission QNZ2025061the Sixth People's Hospital of Nantong ntly202408
6 · The paper itself

Abstract

Tuberculosis and diabetes mellitus co-morbidity (TB_DM) poses harmful for human health and not conducive to early control. The gut microbiota has been proven to play an important role in a variety of diseases. In this study, we investigated the characteristics of the intestinal flora according to 16s rRNA sequencing results in their fecal samples in TB_DM, screened out independent bacterial genera to determine their diagnostic alone and in combination and explore their biological functions. A total 128 patients of 40 patients with diabetes mellitus (DM group), 40 patients with tuberculosis (TB group), 48 patients with TB_DM who met inclusion and exclusion criteria and 40 healthy persons as control group (HC group). We found that the sparse curves of the four groups were stable. The OTU analysis showed the most genus classification in the HC group and the least ones in the TB_DM group. Compared with the HC group, the α and β diversity were significantly decreased in the DM, TB and TB_DM group, particularly in TB_DM group. In the screening of independent genera, top 14 differential genera were found between the DM and the TB_DM group and top 18 ones between the TB and the TB_DM group.The top 3 bacterial genera Enterococcus, Flavonifractor and Romboutsia between DM and TB_DM groups were identified for analyzing diagnostic efficacy. The AUC, 95%CI, sensitivity and specificity were 0.742, 0.638 ~ 0.846, 64.58% and 80.00% in Enterococcus; 0.663, 0.547 ~ 0.779, 75.00% and 60.00% in Flavonifractor; 0.646, 0.530 ~ 0.762, 54.17% and 77.50% in Romboutsia and 0.835, 0.752 ~ 0.918, 79.17% and 75.00% in combined them, respectively. Also, the top 3 different genera Paeniclostridium, Dialister, and Lachnospira were found between TB and TB_DM groups for evaluating above diagnostic efficacy. The AUC, 95%CI, sensitivity and specificity were 0.716, 0.607 ~ 0.824, 81.25% and 57.50% in Paeniclostridium; 0.689, 0.575 ~ 0.803, 87.50% and 50.00% in Dialister; 0.672, 0.557–0.786, 83.33% and 55.00% in Lachnospira; and 0.914, 0.853 ~ 0.975, 85.42% and 85.00% in combined them, respectively. PICRUSt2 analysis indicated that differentially expressed genes (DEGs) predominantly influenced porphyrin and chlorophyll metabolism, pantothenate and CoA biosynthesis, as well as D-alanine metabolism between the DM and TB_DM groups. Furthermore, the DEGs were primarily associated with porphyrin and chlorophyll metabolism, Alzheimer’s disease and carotenoid biosynthesis when comparing the TB group to the TB_DM group. Our results provide key insights into the intestinal flora diversity, function and its independent genus in distinguishing TB_DM, TB and DM patients.

Indexed as

BacteriaDiabetes MellitusGastrointestinal MicrobiomeTuberculosisAdultAgedComorbidityDNA, BacterialFecesFemaleHumansMaleMiddle AgedRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16SBiological functionIndependent genusMolecular markerSample diversityTuberculosis and diabetes mellitus co-morbidity gut microbiota

Identifiers

PMID41742016
PMCPMC13041053

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.